Skip to main content

Mark J. Frohlich

Equibles does not estimate personal net worth.

Get an email with a short summary when Rigel Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get RIGL alerts

About Mark J. Frohlich

Mark J. Frohlich is recorded as Board Member at Rigel Pharmaceuticals Inc (RIGL) since March 6, 2025. Rigel Pharmaceuticals Inc reported in an 8-K filed March 10, 2025 that Mark J. Frohlich was appointed board of directors, effective March 6, 2025. Rigel Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rigel Pharmaceuticals Inc includes Raul R. Rodriguez (CEO and Board Member), Raul Rodriguez (CEO and Board Member), Dean Schorno (CFO) and 7 others.

“On March 6, 2025 (the “Effective Date”), Mark J. Frohlich was appointed to serve on the board of directors (the “Board”) of Rigel Pharmaceuticals, Inc. (“Rigel” or the “Company”), upon the recommendation of the Board’s Corporate Governance, Health Care Compliance Oversight and Nominating Committee, until his successor is elected and has qualified, or sooner in the event of his death, resignation or removal.”
Rigel Pharmaceuticals Inc Form 8-K, filed March 10, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Rigel Pharmaceuticals Inc

Recent activity